Differentiation and Treatment of Hypertension Comorbidities from the Perspective of "Constitution-Syndrome-Disease Location Correlation"

GAO Mengqi; WANG Anlu; XU Hao

doi:10.13288/j.11-2166/r.2026.10.006

您当前的位置：

首页 >

文章列表页 >

Differentiation and Treatment of Hypertension Comorbidities from the Perspective of "Constitution-Syndrome-Disease Location Correlation"

更新时间：2026-05-19

- Differentiation and Treatment of Hypertension Comorbidities from the Perspective of "Constitution-Syndrome-Disease Location Correlation"
- Journal of Traditional Chinese Medicine Vol. 67, Issue 10, Pages: 1057-1061(2026)
- 作者机构：
  
  1.中国中医科学院西苑医院国家中医心血管病临床医学研究中心，北京市海淀区西苑操场1号，100091
  2.中国中医科学院博士后流动站
  3.中国中医科学院西苑医院
  4.中国中医科学院西苑医院苏州医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2026.10.006
  CLC：
- Received：19 January 2026，
  
  Revised：2026-02-06，
  
  Accepted：28 January 2026，
  
  Published：17 May 2026
- 稿件说明：
移动端阅览
高梦琦,王安璐,徐浩.从“体质-证候-病位相关”探讨高血压共病的中医辨治思路[J].中医杂志,2026,67(10):1057-1061.

GAO Mengqi,WANG Anlu,XU Hao.Differentiation and Treatment of Hypertension Comorbidities from the Perspective of "Constitution-Syndrome-Disease Location Correlation"[J].Journal of Traditional Chinese Medicine,2026,67(10):1057-1061.
高梦琦,王安璐,徐浩.从“体质-证候-病位相关”探讨高血压共病的中医辨治思路[J].中医杂志,2026,67(10):1057-1061. DOI： 10.13288/j.11-2166/r.2026.10.006.

GAO Mengqi,WANG Anlu,XU Hao.Differentiation and Treatment of Hypertension Comorbidities from the Perspective of "Constitution-Syndrome-Disease Location Correlation"[J].Journal of Traditional Chinese Medicine,2026,67(10):1057-1061. DOI： 10.13288/j.11-2166/r.2026.10.006.

摘要

以“体质-证候-病位相关”思路为主线构建高血压共病的中医认识框架。从共同的体质基础和相近的病机特点来看，高血压共病并非多种疾病的简单叠加，而是在阴虚质、气虚质、阳虚质、痰湿质、湿热质、血瘀质等偏颇体质基础上，伴随风、火、痰、瘀、虚等证候长期交织，并在肝、心、脾、肾等病位网络中逐步外化为不同系统的共病。在此基础上，以心系、脑系、肾系及代谢相关共病为主要类型，对其体质、证候、病位特征进行归纳整合，揭示共性病机与病位偏重的对应关系，并提出相应防治思路。将体质分层融入危险分层以前瞻干预，以证候为枢纽形成益气活血、化痰通络等多病同治策略，构建涵盖体质评估、证候辨识、共病风险分层、中西医协同干预及随访反馈的临床路径，为高血压共病的中医理论建构与协同管理提供参考。

Abstract

Mainly based on the "constitution-syndrome-disease location correlation" approach， this study constructs a traditional Chinese medicine （TCM） framework for understanding hypertension comorbidities. From the perspective of shared constitutional predispositions and similar pathomechanistic characteristics， hypertension comorbidity should not be regarded as a simple aggregation of multiple diseases. Rather， it is generally rooted in biased constitutions such as

yin

-deficiency，

yang

-deficiency， phlegm-dampness， dampness-heat， and blood-stasis constitutions， accompanied by the long-term interplay of pathogenic mechanisms involving wind， fire， phlegm， stasis， and deficiency， and gradually manifests as comorbidities affecting different

systems through the evolution of disease locations related to the liver， heart， spleen， and kidney. On this basis， cardiac-， cerebral-， renal-， and metabolic-related comorbidities are taken as the major categories， and their characteristics related to constitution， syndrome， and disease location are systematically summarized to clarify the correspondence between shared pathomechanisms and predominant disease locations， and to propose corresponding prevention and treatment strategies. This framework further incorporates constitution-based stratification into risk stratification for prospective intervention， and takes syndrome as the central link in developing multi-disease treatment strategies such as boosting

and activating blood， as well as resolving phlegm and unblocking collaterals. A clinical pathway is thereby proposed， encompassing constitution assessment， syndrome differentiation， comorbidity risk stratification， integrated traditional Chinese and western medicine intervention， and follow-up feedback. This study aims to provide a reference for the theoretical development and collaborative management of hypertension comorbidities in TCM.

关键词

Keywords

references

The Writing Committee of the Report on Cardiovascular Health and Diseases in China . Report on cardiovascular health and diseases in china 2021： an updated summary ［J］. Biomed Environ Sci ， 2022 ， 35 （ 7 ）： 573 - 603 .

闫泽玉，陈大方 . 慢性病共病模式研究进展［J］. 中华疾病控制杂志， 2023 ， 27 （ 4 ）： 471 - 475 .

HU Y ， WANG Z ， HE H ， et al . Prevalence and patterns of multimorbidity in China during 2002-2022： a systema-tic review and Meta-analysis ［J］. Ageing Res Rev ， 2024 ， 93 ： 102165 . doi： 10.1016/j.arr.2023.102165 http://dx.doi.org/10.1016/j.arr.2023.102165 .

SKOU S T ， MAIR F S ， FORTIN M ， et al . Multimorbidity ［J］. Nat Rev Dis Primers ， 2022 ， 8 （ 1 ）： 48 .

王琦 . 中医体质学对共病诊疗的理论创新与实践［J］. 北京中医药大学学报， 2025 ， 48 （ 11 ）： 1481 - 1486 .

MCEVOY J W ， MCCARTHY C P ， BRUNO R M ， et al . 2024 ESC Guidelines for the management of elevated blood pressure and hypertension ［J］. Eur Heart J ， 2024 ， 45 （ 38 ）： 3912 - 4018 .

张宇 . 健脾祛湿汤联合择时揿针治疗中青年高血压伴高尿酸血症患者的临床效果［J］. 临床医学研究与实践， 2025 ， 10 （ 29 ）： 113 - 116 .

任园园 . 参松养心胶囊联合缬沙坦治疗高血压伴永久性房颤临床观察［J］. 实用中医药杂志， 2025 ， 41 （ 3 ）： 610 - 613 .

常先松，肖文金 . 祛瘀化痰通脉方治疗高血压合并颈动脉粥样硬化的疗效及对血脂水平的影响［J］. 中药材， 2023 ， 46 （ 2 ）： 499 - 502 .

王琦 . 中医健康状态概念及内涵研究［J］. 中华健康管理学杂志， 2012 ， 6 （ 6 ）： 419 - 420 .

陈洁玲，陈雄森，廖荣鑫，等 . 中医体质类型与高血压前期相关性研究的单个率Meta分析［J］. 世界中医药， 2024 ， 19 （ 19 ）： 2931 - 2941，2957 .

尉敏琦，余峰，诸光花，等 . 808例社区老年高血压病患者中医体质状况与相关因素分析［J］. 中医杂志， 2016 ， 57 （ 3 ）： 228 - 232 .

潘晔，刘志辉，胡倩倩，等 . 中国老年人慢性病多病共存模式的研究［J］. 中国全科医学， 2023 ， 26 （ 29 ）： 3608 - 3615 .

中国老年医学学会高血压分会，北京高血压防治协会，国家老年疾病临床医学研究中心（中国人民解放军总医院，首都医科大学宣武医院） . 中国老年高血压管理指南2023 ［J］. 中华高血压杂志， 2023 ， 31 （ 6 ）： 508 - 538 .

《高血压病治未病干预指南》编写组 . 高血压病治未病干预指南［J］. 北京中医药大学学报， 2023 ， 46 （ 8 ）： 1063 - 1076 .

李书文，王凤荣 . 冠心病与中医体质相关性的研究进展［J］. 实用中医内科杂志， 2025 ， 39 （ 12 ）： 14 - 18 .

毛静远，赵志强，王贤良，等 . 中医药治疗心血管疾病研究述评（2020）［J］. 中医杂志， 2021 ， 62 （ 3 ）： 185 - 188 .

中国心血管病风险评估和管理指南编写联合委员会 . 中国心血管病风险评估和管理指南［J］. 中国循环杂志， 2019 ， 34 （ 1 ）： 4 - 28 .

李金根，徐浩 . 构建中西医结合精准医学新模式：理论提出与实践［J］. 科学通报， 2025 ， 70 （ 35 ）： 5949 - 5955 .

邵明燕，郑艺，林洁，等 . 九种体质生命全周期的免疫力特征模式及调体干预的研究述评［J］. 中华中医药杂志， 2025 ， 40 （ 7 ）： 3285 - 3288 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Application Value and Pathways of Traditional Chinese Medicine Constitution Theory in Elderly Health Management

Current Status and Strategic Recommendations for Randomized Controlled Trials on Functional Dyspepsia-Irritable Bowel Syndrome Comorbidity：from a Real-World Research Perspective

Current Status and Prospective of Research on Disease-Syndrome Integrated Animal Models of Spleen and Stomach Diseases in Traditional Chinese Medicine

Application Value of Scales for Symptom & Syndrome Evaluation in Spleen-Stomach Diseases Related New Drug Research and Development

Standardized Expressions for the Statement that "a Certain Disease in Western Medicine Falls Within the Category of a Certain Disease or Syndrome in Traditional Chinese Medicine"

Related Author

LI Zhuqing

LI Meiqing

ZHENG Xiaohong

DAI Ning

JIANG Linlin

ZHANG Huie

LU Fang

ZHANG Jiaqi

Related Institution

School of Traditional Chinese Medicine，Nanjing University of Chinese Medicine

Shandong Medical College

Xiyuan Hospital，China Academy of Chinese Medical Sciences

Institute of Spleen and Stomach Diseases，Xiyuan Hospital，China Academy of Chinese Medical Sciences

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰